CCR6 and chronic myelogenous leukemia, BCR-ABL1 positive: Hromas et al., however, claimed that CCR7 ligands, CCL19 and CCL21, and a CCR6 ligand, CCL20, inhibited proliferation of CML progenitor cells as well as normal progenitor cells [101].